Journal of Commercial Biotechnology — May 2011 issue now available

The May 2011 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 17, Issue 2

Editorial

Building biotechnology in Okinawa	PDF
Yali Friedman

Commentary

Startup America: What it includes and opportunities for innovators	PDF
David B Orange

Singapore – Home base for expansion in Asia	PDF
Kian-Teik Beh

Traditional ecological knowledge: Impact on commercial health	PDF
Mohammadali Khalvati, Ikway (Yvonne Fulton) Michine, Wabiska (Zane Bell) Mukwa, Mary Jane Metatawabin

Articles

The growing importance of incorporating US payers into biotechnology drug development decision-making	PDF
Sarah Collins

Anticipating opportunities in industrial biotechnology: Sizing the market and growth scenarios	PDF
Peter J Nieuwenhuizen, David Lyon

Founding angels as early stage investment model to foster biotechnology start-ups	PDF
Gunter Festel

The economic potential of plant-made pharmaceuticals in the manufacture of biologic pharmaceuticals	PDF
James Kaufman, Nicholas Kalaitzandonakes

From the Classroom

Developing graduate skills for the United Kingdom’s commercial life science sector: Experiences from the ORBIS internship programme	PDF
James Gazzard

Legal and Regulatory Updates

EU Legal and Regulatory Update	PDF
Gerry Kamstra

Impact of recent IP caselaw on biomarkers and personalized medicine	PDF
David A Gass

Licensing issues in today’s bankruptcy world	PDF
Michael Schein, Brandon J Fleischman

Limitation of gene patents to functioning DNA	PDF
Philip Webber

Book Reviews

Chronicling the development of myozyme: The Cure and Chasing Miracles	PDF
Derek J Francis

Anatomy of a Patent Case	PDF
Michael G Sullivan